CN
101-99-5
应用筛选条件
关键词:'101-99-5'
显示 1-30 共 309 条结果 关于 "101-99-5" 范围 技术文档
The Effective Use of Protein Kinase Inhibitors
89 106 101 56 5 89 99 93 96 101 94 99 116 109 94 94 90
MAPK2/ERK2 87 94 94 139 92 92 107 85 85 89 90 114 113 90 107 102 97 98 107
JNK1α1/SAPK1c
The Effective Use of Protein Kinase Inhibitors
89 106 101 56 5 89 99 93 96 101 94 99 116 109 94 94 90
MAPK2/ERK2 87 94 94 139 92 92 107 85 85 89 90 114 113 90 107 102 97 98 107
JNK1α1/SAPK1c
5-Bromo-3-indolyl b-D -galactopyranoside (B2904)
containing pTZ 18R cells produced blue colonies
within 24 hours and the JM 101 cells produced only white
colonies after 48 hours.
5/99
Quality Control Range Sheet- HCY-116 and HCY-216
IL-5 Control 1 110 – 229 pg/mL MIP-1β Control 1 88 – 182 pg/mL
Control 2 534 – 1109 pg/mL Control 2 419 – 870 pg/mL
Quality Control Ranges - Milliplex Mouse Cytokine/Chemokine Magnetic Panel
IL-5 Control 1 92 - 192 pg/mL IP-10 Control 1 101 - 210 pg/mL
Control 2 527 - 1095 pg/mL Control 2 522 - 1083 pg/mL
Verfication summary-03-0202-00
106.83 5.9 6% -
3 1:8 13.33 0.9 7% 106.61 7.0 7% 100%
3 1:16 6.87 0.4 5% 109.98 5.8 5% 103%
2 1:32 3.37 0.3 9% 107.84 10.2 9% 101%
Verfication summary-03-0202-00
106.83 5.9 6% -
3 1:8 13.33 0.9 7% 106.61 7.0 7% 100%
3 1:16 6.87 0.4 5% 109.98 5.8 5% 103%
2 1:32 3.37 0.3 9% 107.84 10.2 9% 101%
Quality Control Ranges: Milliplex Human Cytokine / Chemokine Immunoassay
IL-5 Control 1 107 – 222 pg/mL TNF β Control 1 106 – 221 pg/mL
Control 2 493 – 1024 pg/mL Control 2 537 – 1115 pg/mL
DECLARATION OF CONFORMITY BenchMixer Vortex mixer and Mortexer Vortex mixer
Directive 2004/108/EC
Harmonized Standards: EN 61010-1:01
EN 61010-2-101:02
EN 61010-2-051:95
EN 55011:98/A1:99/A2:02
EN 61000-3-2:00+A2:05
EN 61000-3-3:95+A1:01+A2:05
Data Sheet - P5622
407, 48-54 (2000).
4. Francis, R., et al., Dev. Cell, 3, 85-97 (2002).
5. Goutte, C., et al., Proc. Natl. Acad. Sci. USA, 99,
775-779 (2002).
6. Kimberly, W.T., et al., Proc. Natl. Acad. Sci.
Quality Control Range Sheet- HCC-121A and HCC-221A
214 pg/mL
Control 2 503 – 1045 pg/mL Control 2 541 – 1124 pg/mL
TGF-α Control 1 101 – 211 pg/mL MDC Control
Product Information Sheet - B8385
Antibiot., 29, 97-99; 100-
101, (1976).
3. Umezawa, H., et al., Ann. Rev. Microbiol, 36, 75-99
(1982).
4. Aoyagi , T., et al., Japanese J. Antibiotics, XXX-
supp., S121-123 (1977).
5. Umezawa, H.
Product Information Sheet - SE120011
85 100 105 98 65 120
0.05 104 98 102 104 101 72 112
0.10 100
QC Range Sheet MCKP1-110K
Catalog# MCKP1-110K, MCKP1-110K-PX28, MCKP1-110K-PBK28
Control Catalog # MCKP1-6110 Lot # MCKP1-101 and MCKP1-201
***Additional Analytes on reverse side***
Note: The Quality Control Ranges are
GR 144053- Non-peptide antagonist of the platelet glycoprotein IIb/IIIa (GP IIb/IIIa) fibrinogen receptor
Pharmacol. Sci., 19, 452-460 (1998).
99. Brichard, S.M., et al., Trends Pharmacol. Sci., 16, 265-270 (1995).
100. Watanabe, T., et al., J. Antibiot., 48, 1460-1466 (1995).
101. Lajas, A.I., et al., Mol. Cell
Product Information Sheet - I2396
References
1. Ryff, J.C., Usefulness of interferon for treatment of
hepatitis C. J. Hepatol., 22, 101-109 (1995).
2. Dusheiko, G.M., and Roberts, J.A., Treatment of
Chronic Type B and C Hepatitis with
Instruction Manual: siIMPORTER™ siRNA and Plasmid DNA Transfection Reagent
wells 12.5 + 5 2.50
6 wells 25 + 10 5.00
Cat. #64-101
siIMPORTER™ Transfection Reagent
16
5. Mix gently by pipetting. Do not vortex. Incubate at
room temperature
Data Sheet
250 70 x 145 19 / 26 10
1509024 500 86 x 177 24 / 29 10
1509029 1000 101 x 225 29 / 32 5
1509030 2000 136 x 260 34 / 35 5
Similar
Data Sheet
250 70 x 145 19 / 26 10
1509024 500 86 x 177 24 / 29 10
1509029 1000 101 x 225 29 / 32 5
1509030 2000 136 x 260 34 / 35 5
Similar
Data Sheet - G1424
van Leeuwenhoek,
95, 101-109 (2009).
4. Johnston, K.L., et al., Lipoprotein biosynthesis as a
target for anti-Wolbachia treatment of filarial
nematodes. Parasit. vectors, 3, 99 (2010).
DWF,JB,PHC
Anti-Ubiquitinylated Proteins, clone FK1
,
1188-1195.
5. Bishop, N. et al. (2002) Mammalian class E vps proteins recognize ubiquitin and act in the removal of
endosomal protein-ubiquitin conjugates. J. Cell Biol., 157: 91-101 (2002).
6. Lelouard
Data Sheet - A8535
10000
15000
20000
25000
30000
35000
m/z
Abundance
42
58
63 77 91 101 107 115 128 141 152 165 178 189 202 215 232
Hewlett-Packard 5890 Series II
S(–)-Blebbistatin: Selective inhibitor ofnon-muscle myosin II
knockout mice”. In: Advances in Prostaglandin
and Leukotriene Research (Eds. Samuelsson, B. et al.) pp 99-101; Kluwer
Academic, The Netherlands (2001).
Monoclonal Anti-γ Parvin: Focal adhesion
protein
Antibody to VE-Cadherin (CD144)- Endothelial cell-specific marker
1992).
4. Hendrix, M.J., et al., Proc. Natl. Acad. Sci. USA, 98, 8018-8023 (2001).
5. Zhou, Y., et al., J. Clin. Invest., 99, 2139-2151 (1997).
6. Smith, M.E., et al., Histopathology, 32, 411-413 (1998).
Data Sheet - P7605
Radiat. Res. 101, 4 (1985).
4. Le Rhun, Y., et al., Biochem. Biophys. Res.
Commun. 245, 1 (1998).
5. Shah, G.M., et al., Biochem. Biophys. Res.
Commun. 229, 838 (1996).
lpg 10/99
Quality Control Range Sheet- A60MG-105 and A60MG-205
mL Control 2 673 - 1398 pg/mL
GM-CSF Control 1 72 - 150 pg/mL IL-12(p70) Control1 101 - 210 pg/ml
Control 2 397
Product Information Sheet - A4316
natriuretic peptide and
somatostatin secretion in the antrum of the
stomach. Regul. Pept., 110(2), 101-116 (2003).
11. Gower, W. R., Jr., et al., Gastric atrial natriuretic
peptide regulates endocrine
Anti-Brg1/hSNF2beta (B8184)
Guschin, D., J. Struct. Biol., 129,
102-122 (2000).
4. Bird, A., and Wolffe, A.P., Cell, 99, 451-454
(1999).
5. Sudarsanam, P., and Winston, F., TIG, 16,
345-350 (2000).
6. Wang, W., et al., EMBO
Protocol: Rat/Mouse Ghrelin (Active)
94% 110 100%
5 µL 54 102% 57 103%
Rat
20 µL 640 100% 607 100%
15 µL
Data Sheet - H9787
, D., J. Struct. Biol., 129,
102-122 (2000).
4. Bird, A., and Wolffe, A.P., Cell, 99, 451-454
(1999).
5. Sudarsanam, P., and Winston, F., TIG, 16,
345-350 (2000).
6. Wang, W.
1/11